The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Migraine
- Migraine With Aura
- Migraine Without Aura
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Randomized, double-blinded, placebo-controlled, parallel study followed by a 6-month open-label extension.Masking: Double (Participant, Investigator)Primary Purpose: Health Services Research
Participation Requirements
- Age
- Between 18 years and 60 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04452929
- Collaborators
- Novartis Pharmaceuticals
- Investigators
- Study Director: Thien P Do, MD Danish Headache Center
Get Well Soon